How to translate text using browser tools
30 April 2014 Dosage Compensation of an Aneuploid Genome in Mouse Spermatogenic Cells
Petr Jansa, David Homolka, Radek Blatny, Martin Mistrik, Jiri Bartek, Jiri Forejt
Author Affiliations +
Abstract

Autosomal trisomies and monosomies bring serious threats to embryonic development through transcriptional disarray caused primarily by the dosage effect of the aneuploid part of the genome. The present study compared the effect of a mouse-viable 30-Mb segmental trisomy on the genome-wide transcriptional profile of somatic (liver) cells and male germ cells. Although the 1.6-fold change in expression of triplicated genes reflected the gene dosage in liver cells, the extra copy genes were compensated in early pachytene spermatocytes, showing 1.18-fold increase. Although more pronounced, the dosage compensation of trisomic genes was concordant with the incidence of HORMAD2 protein and histone gammaH2AX markers of unsynapsed chromatin. A possible explanation for this includes insufficient sensitivity to detect the meiotic silencing of unsynapsed chromatin markers in the 30-Mb region of the chromosome or an earlier silencing effect of another epigenetic factor. Taken together, our results indicate that the meiotic silencing of unsynapsed chromatin is the major, but most likely not the only, factor driving the dosage compensation of triplicated genes in primary spermatocytes.

Petr Jansa, David Homolka, Radek Blatny, Martin Mistrik, Jiri Bartek, and Jiri Forejt "Dosage Compensation of an Aneuploid Genome in Mouse Spermatogenic Cells," Biology of Reproduction 90(6), (30 April 2014). https://doi.org/10.1095/biolreprod.114.118497
Received: 10 February 2014; Accepted: 1 April 2014; Published: 30 April 2014
KEYWORDS
gene dosage
male sterility
meiotic silencing of unsynapsed chromatin
pachytene spermatocytes
segmental trisomy
synaptonemal complex
transcriptional profiling
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top